SIGA
SIGA Technologies, Inc.
1W: -2.4%
1M: -27.1%
3M: -20.4%
YTD: -20.9%
1Y: -6.9%
3Y: +18.1%
5Y: -0.6%
$4.96
-0.03 (-0.60%)
After Hours: $5.30 (+0.34, +6.96%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$355.4M
52W Range4.81-9.62
Volume691,580
Avg Volume488,333
Beta0.99
Dividend$0.60
Analyst Ratings
Company Info
CEODiem Nguyen
Employees46
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1997-09-10
Websitesiga.com
31 East 62nd Street
New York City, NY 10065
US
New York City, NY 10065
US
212 672 9100
About SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Miller Larry R. | M-Exempt | 6,920 | — | 2026-03-25 |
| Miller Larry R. | F-InKind | 3,526 | $4.99 | 2026-03-25 |
| Miller Larry R. | M-Exempt | 6,920 | — | 2026-03-25 |
| Luckshire Daniel J | M-Exempt | 11,503 | — | 2026-03-13 |
| Luckshire Daniel J | F-InKind | 6,074 | $5.26 | 2026-03-13 |